Literature DB >> 19249315

Enhanced vascular contractility in alpha1-adrenergic receptor-deficient mice.

Atsushi Sanbe1, Yoshio Tanaka, Yoko Fujiwara, Noriko Miyauchi, Reiko Mizutani, Junji Yamauchi, Susanna Cotecchia, Katsuo Koike, Gozoh Tsujimoto, Akito Tanoue.   

Abstract

AIM: Alpha1-adrenergic receptors (alpha1-ARs) are classified into three subtypes: alpha1A-AR, alpha1B-AR, and alpha1D-AR. Triple disruption of alpha1A-AR, alpha1B-AR, and alpha1D-AR genes results in hypotension and produces no contractile response of the thoracic aorta to noradrenalin. Presently, we characterized vascular contractility against other vasoconstrictors, such as potassium, prostaglandin F2alpha (PGF(2alpha)) and 5-hydroxytryptamine (5-HT), in alpha1A-AR, alpha1B-AR, and alpha1D-AR triple knockout (alpha1-AR triple KO) mice. MAIN
METHODS: The contractile responses to the stimulation with vasoconstrictors were studied using isolated thoracic aorta. KEY
FINDINGS: As a result, the phasic and tonic contraction induced by a high concentration of potassium (20 mM) was enhanced in the isolated thoracic aorta of alpha1-AR triple KO mice compared with that of wild-type (WT) mice. In addition, vascular responses to PGF(2alpha) and 5-HT were also enhanced in the isolated thoracic aorta of alpha1-AR triple KO mice compared with WT mice. Similar to in vitro findings with isolated thoracic aorta, in vivo pressor responses to PGF(2alpha) were enhanced in alpha1-AR triple KO mice. Real-time reverse transcription-polymerase chain reaction analysis and western blot analysis indicate that gene expression of the 5-hydroxytryptamine 2A (5-HT(2A)) receptor was up-regulated in the thoracic aorta of alpha1-AR triple KO mice while the prostaglandin F2alpha receptor (FP) was unchanged. SIGNIFICANCE: These results suggest that loss of alpha1-ARs can lead to enhancement of vascular responsiveness to the vasoconstrictors and may imply that alpha1-ARs and the subsequent signaling regulate the vascular responsiveness to other stimulations such as depolarization, 5-HT and PGF(2alpha).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249315     DOI: 10.1016/j.lfs.2009.02.020

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Lack of changes in carotid artery compliance with systemic nitric oxide synthase inhibition.

Authors:  J Sugawara; Y Saito; S Maeda; M Yoshizawa; H Komine; M Nakamura; R Ajisaka; H Tanaka
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.